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Abstract 
 
Objective: The objective of this selective EBM review is to determine whether or not coconut oil 
is effective in treating dermatologic conditions, particularly acute tungiasis and atopic dermatitis, 
which cause xerosis, skin atrophy, and lesions.  
 
Study Design: This is a systematic review of a cohort study and two double blind randomized 
control trials written in English, published between 2008 – 2015.  
 
Data Sources: Resources for this review were found through peer reviewed articles published on 
PubMed databases 
 
Outcomes Measured: Appearance of the lesions caused by atopic dermatitis or acute tungiasis 
were assessed in regards to size, erythema, edema, and oozing, as well as subjective factors such 
as the intensity of the pruritis, sleep loss, and pain. 
 
Results: Out of the three studies analyzing the effects of coconut oil, all found that coconut oil is 
effective in improving dermatologic conditions. In Evangelista et al.’s study, using a SCORAD 
(scoring atopic dermatitis), significant improvements (CI=95%; p=0.001) in pediatric atopic 
dermatitis group using coconut oil were noted. There was a 68.23% and 38.13% improvement in 
the coconut oil group and mineral oil group respectively1. In Verallo-Rowell et al.’s study, there 
was a significant improvement (CI=95%, p=0.004) in the SCORAD for adult atopic dermatitis, 
with a 46.8% and 30.% improvement in the coconut oil group and the control mineral oil group 
respectively6. In Gitau et al.’s cohort study, from baseline, there was a significant improvement 
(p=0.001) in acute tungiasis symptoms by 67.8% from baseline2. 
 
Conclusions: These studies show that coconut oil can significantly improve symptoms of atopic 
dermatitis and acute tungiasis. Though studies did not include several other dermatologic 
conditions, coconut oil shows to improve lesions and discomfort. 
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Introduction 
 
 Dermatologic conditions are not only uncomfortable to the patient, causing pain, pruritis, 
distress, etc., but there is a cosmetic component to them too. Each condition affects the skin in a 
different manner, which causes various discomforts and can make an individual self-conscious. 
Furthermore, conditions such as atopic dermatitis can become scabbed if not taken care of 
properly, causing it to colonize bacteria such as Staphylococcus aureus, and leading to further 
infection1. tungiasis has a similar cosmetic effect with discomfort, however this is manifested 
due to a type of flea2. The studies reviewed in this article evaluate the effectiveness of coconut 
oil on alleviating the symptoms caused by these conditions, as well as the appearance of the 
lesions. 
 Though tungiasis is not very commonly seen in the United States, assessing this article 
could evaluate the effect of coconut oil on this parasite caused dermatologic condition2. 
Evaluating the results could promote efforts to get this easily accessible product available to third 
world countries where the tungiasis flea, as well as other dermatologic conditions, are a major 
issue. On the contrary, atopic dermatitis is very prevalent in the United States with about 10-20% 
of children and about 1-3% of adults diagnosed4. Because of the prevalence, any sort of clinician, 
especially one working with the pediatric population, is very to be likely exposed to this. 
 Coconut oil is a very accessible product that can be ordered online, or found at drug 
stores and various supercenters. It is an affordable product that can be purchased over the 
counter, and therefore does not need to go through insurance and a clinician.  
 About 12% of all family practice visits are dermatology related, which on average would 
have doctors seeing skin related issues daily4. Tungiasis is rarely seen in the United States, but is 
fairly common in rural, impoverished places in Africa and South America where the Tunga 
	   Olshanskaya,	  Coconut	  Oil	  in	  Dermatology,	  p.	  2	  
	  
penetrans flea is native2. Individuals who commonly come in close contact with animals, do not 
have proper foot attire, or walk barefoot are at a greater risk for infection2. On the contrary, a 
significant amount of people are affected by atopic dermatitis, and though several cases do not 
require consistent doctor’s visits, individuals still need to find a way to keep the ailment under 
control.  
 Atopic dermatitis is a condition that causes weakness and decreased effectiveness of the 
epithelial layer of the skin1. This often causes bacterial colonization as well as dryness, 
discomfort, xerosis and more progressive lesions. The reason this process occurs is still 
unknown.1 Tungiasis is caused by a flea that results in skin atrophy, pain, and itchiness2. 
Extensive data has not been conducted to analyze the long term effects, but cases of septicemia 
and lymphangitis have been noted as complications5.  
 Usually chemotherapy type drugs, such as hydrogen peroxide and potassium 
permanganate, are the treatment of choice for acute tungiasis. Unfortunately these are expensive 
and hard to attain in impoverished areas such as the ones affected by this flea. For atopic 
dermatitis, various moisturizers, eucerin, and aquaphor are the treatment of choice for mild 
cases, with antihistamine creams or pills to alleviate itching. Steroidal and nonsteroid creams (for 
atopic dermatitis on the face) are typically used when basic moisturizers are not enough1.  
 Topical coconut oil is the proposed treatment for these conditions that causes visible 
lesions and discomfort. Coconut oil has shown to decrease itching, erythema, and other signs and 
symptoms of the problem1,2,6. Coconut oil also decreased bacterial and parasitic colonization, 
which in turn would cause less discomfort and infection in participants2,6.  
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Objective 
 The objective of this selective EBM review is to determine whether or not coconut oil is 
effective in treating dermatologic conditions, particularly acute tungiasis and atopic dermatitis, 
which cause xerosis, skin atrophy, and lesions. 
 
Methods 
 Two double blind, randomized control trials were used to evaluate atopic dermatitis, 
while a cohort study was used to evaluate the effects of coconut oil on acute tungiasis1,2,6. 
Individuals with the dermatologic condition of choice that have visible lesions which cause 
discomfort are recruited for the study. In the atopic dermatitis studies, patients with infected 
lesions, more complicated underlying diseases, or requiring antibiotics were not used in these 
trials1,6. Coconut oil was used as the intervention and applied on the affected area. These results 
were compared to the control group treated either with olive oil or mineral oil1,6. The results of 
the acute tungiasis cohort study were compared to the status of the lesion and infestation prior to 
the application of coconut oil2. Those under two years old or with ulcerated lesions were not 
included in this study, and were sent to a hospital2. Objective and subjective results were 
evaluated, including pruritis, size of lesion, crusting, weeping of the lesion, and pain.  
 When searching for the articles, the key words were “coconut oil” and after a basis of 
what kind of studies had been established, “dermatology” was another key word. All information 
that was even considered needed to be written in English. The articles used were published in 
journals and found through PubMed, and evaluated the effect of coconut oil on a specific 
condition. The articles were selected based on how relative they were to the research topic and 
whether or not they were measuring patient oriented outcomes (POEMS). Studies found before 
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2007 were excluded. Articles that only analyzed disease oriented outcomes (DOES) were also 
not selected in this review. The selected studies reported the results through a Z score, NNT and 
p-value. 
 
Table 1: Study generalizations 
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Outcomes Measured 
 The outcomes for the atopic dermatitis studies were measured through a SCORAD 
(scoring atopic dermatitis), which assess objective and subjective improvement. It assessed 
lesion appearance, pruritis, intensity, sleep loss, and lesion morphology. A study even correlated 
the results if the SCORAD with Staph aureus colonization via culture1,7. Gitau et al.’s study uses 
before and after objective and subjective measurements regarding difficulty walking due to the 
tungiasis manifestation, inflammation measurements, pustules, abscesses, ulceration, and flea 
infestation. The initial assessments were given a score and compared to the results after the 
treatment2.  
 
Results 
 Three studies were used to examine the effects of coconut oil on dermatologic 
conditions1,2,6. One study examined patients under 13 years old1, another examined adults 
between the ages of 18-40 years old6, and the last examined a large age range of patients 2-60 
years old2. The effects of the coconut oil were either compared to a control group using a 
different type of oil1,6, or to the subjective and objective measurements recorded before the 
treatment was initiated2. The results of the following three studies showed no significant 
difference in the results between age and sex. 
 In the study by Evangelista et al, pediatric patients between the ages of 1 and 13 with 
uncomplicated atopic dermatitis were included in the double blind randomized control trial1. 
Excluded were children with severe atopic dermatitis, required antibiotics, have concurrent 
dermatology problems, or had a hypersensitivity reaction to coconut or mineral oil. 117 of 132 
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children that fit the inclusion criteria were randomly split into groups that would receive the 
mineral oil or coconut oil. 4 children were considered drop outs because of poor compliance, and 
8 children had to be withdrawn due to adverse effects (which were not discussed in the article), 
applying addition emollients, and poor compliance. At baseline, there were no statistically 
significant differences in average age, number of years with atopic dermatitis, sex, SCORAD, 
sex, or lesion morphology. After 8 weeks of treatment, the SCORAD reduction in the virgin 
coconut oil group (VCO) was 68.23%, which was significant higher (p value < 0.001) compared 
to the mineral oil group, which had a SCORAD reduction of 38.13%. Overall, 93% of the 
patients in the VCO group improved, compared to the 53% of he patients in the mineral oil 
group. The VCO group had 47% (28/59 patients) achieve moderate improvement and 46% 
(27/59 patients) have an excellent response. With mineral oil, 34% (20/58 patients) had moderate 
improvement, and 19% (11/58 patients) had excellent improvement. Relative risk reduction 
(RRR) showed that VCO improved SCORAD values 85.44% more than mineral oil with a 95% 
confidence interval. The number needed to treat (NNT) was 3 and 4 patients to have moderate 
and excellent improvement respectively. This would show a large effect, which this study 
absolutely does. Absolute risk reduction is 39.77%, favoring VCO with a 95% confidence 
interval.  
 In the study by Verallo-Rowell et al., 52 participants between the ages of 18 and 40 with 
atopic dermatitis were assessed and placed in a double blind randomized control trial evaluating 
the effect of virgin coconut oil (VCO) and virgin olive oil (VOO)6. Between the two randomized 
groups, there was no significant difference between age, sex, pruritis, how many years/months 
the patient has had the illness, and lesion morphology. There was also no significant difference 
in SCORAD scores between the two groups prior to intervention (p = 0.15). Individuals who 
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were taking steroids or antibiotics 2 weeks prior, had severe disease state or concurrent 
dermatologic conditions, immunocompromised, diabetic, or had an allergy to VOO or VCO, 
were not invited to participate in the study. There were no withdrawals for any reason in this 
trial. Patients were given 5ml bottles of either VCO or VOO everyday and were told to apply to 
the affected area. They were also given soap that they were told to use in shower. After 4 weeks, 
the SCORAD scored decreased 46.8% in the VCO group, and 30.1% in the VOO. The p value = 
0.004 and a 95% confidence interval in that there is a significant difference between the 
outcomes. The NNT here was 3, so the results prove that the treatment has a large effect. The 
numbers needed to harm (NNH) for this study was 2 6.  
 In Gitau et al.’s article, a cohort study of 39 individuals between the ages of 3 and 60 
were used to study the effects coconut oil on the lesions caused by the Tunga Penetrans flea2. 
Individuals under 2 years old or with severe ulcerations were excluded from the study. To be 
included, one must currently have more than 10 lesions. About 2ml of coconut oil was applied 
twice a day for 30 days by community health workers. Signs and symptoms such as erythema, 
edema, warmth, pustules, suppuration, and itching, as well as flea manifestation levels were 
assessed before and after the intervention. The signs and symptoms caused by the fleas were 
referred to as the severity scores. These severity scores were shown to statistically significantly 
decrease after the 10 week long intervention. The study used a mean change from baseline for 
the severity score, which turned out to be -2.17 (decreasing from a value of 3.2 to 1.03), a 67.8% 
decrease. This translates to a Z score of -3.946 and a p value of 0.001. No participants withdrew 
from the study, nor were there adverse effects from the treatment noted in the article2.  
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Table 2: Statistical values 
 SCORAD/severity 
improvement w 
coconut oil 
SCORAD/severity 
improvement with 
control 
RRR ARR NNT NNH CI p 
value 
Evangelista 
et al. 
68.23% 38.13% 85.4% 39.7% 3: moderate 
improvement 
4: excellent 
improvement 
- 95% 0.001 
Verallo-
Rowell et 
al. 
48.6% 30.1% - - 3 2 95% 0.004 
Gitau et al. 67.8% - - - - - - 0.001 
 
 
Discussion 
 In the Evangelist et al study, parents were given the oil treatments in a bottle, and were 
told to apply it to their child after a 5-10 minute long bath each night1. This leaves room for some 
error in the fact that some children may have had a longer baths, which could dry out their skin 
more, or some parents may have applied the treatment more generously than others. 
Furthermore, the SCORAD analyzes disease oriented outcomes as well patient oriented 
outcomes, which could slightly skew the results for how effective coconut oil is just for the 
patient oriented outcomes. This study only looks at pediatric patients, which would not 
necessarily allow the results to be generalized. The adverse reactions were not elaborated upon in 
the study, so it is unknown if it was due to the treatment or not.  
 Once again, in Verallo-Rowell et al.’s study, participants applied the treatments to 
themselves, so the application may have differed between the groups. Furthermore, participants 
may have applied additional emollients without letting the researchers know, which would alter 
results of the effectiveness as well6.  
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 Coconut oil is not a drug that is regulated by pharmaceutical companies and is easily 
accessible in places like the United States, unlike other third world countries where acute 
tungiasis is a problem. Unless the product is brought, and distributed there, individuals will most 
likely not be able to acquire the coconut oil. Though the results did show coconut oil to 
significantly improve lesions and symptoms caused by the flea, the study did not have a control 
group to compare the results of coconut oil against the natural process2. This study had further 
limitations in that the people in Kenya, where this study was performed, typically walk around 
barefoot, so aiding in the recovery is generally difficult since participants are exposed to bacteria 
that may prevent the coconut oil from being fully effective. Many of the fleas manifest on the 
feet and between the toes, which makes not wearing shoes very relevant to the healing process2.  
 Coconut oil has been shown to have antimicrobial and antibacterial properties, which 
would decrease the level of the inflammation and infection as well as the symptoms caused by 
the infection2. A study that compares the efficacy of coconut oil of severe disease states to 
mild/moderate states would be beneficial for the population to further determine exactly how 
effective coconut oil is as a treatment, or up to what point on the severity scale it would be 
effective.  
 
Conclusion  
 Since the studies only included individuals without severe disease or complications, 
coconut oil can be used as an effective first line treatment in dermatologic conditions before 
advancing to more serious medications with potentially harmful side effects. The studies all 
showed significant improvement with coconut oil with a p value of 0.004 or less, even when 
compared to another oil product, which would also help moisturize and potentially treat a 
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dermatologic condition1. But regardless, coconut oil would be a great treatment, or “add on” 
treatment for dermatologic conditions, particularly those causing itching, ulceration, and lesions, 
since each of the studies showed improvement in those regards. Later studies should evaluate the 
effects of coconut oil on various other dermatologic conditions such as psoriasis, rosacea and 
lichen simplex chronicus, to evaluate the pattern of what coconut oil is most effective against. 
The three analyzed studies had compared the results between various age groups and genders, 
which showed no difference in the improvement. However, there was no comparison between 
the ethnicities. Although radical differences are not expected, this could reaffirm that coconut oil 
has equal effects with not only age and gender, but ethnicity and different skin types as well.  
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